1. Magann EF, Haram K, Ounpraseuth S, Mortensen JH, Spencer HJ, Morrison JC. Use of antenatal corticosteroids in special circumstances: a comprehensive review. Acta obstetricia et gynecologica Scandinavica. 2017;96(4):395-409.
2. Masters AK, Berger DJ, Ware WA, Langenfeld NR, Coetzee JF, Mochel JP, et al. Effects of short-term anti-inflammatory glucocorticoid treatment on clinicopathologic, echocardiographic, and hemodynamic variables in systemically healthy dogs. American journal of veterinary research. 2018;79(4):411-23.
3. Ohta H, Kojima K, Yokoyama N, Sasaki N, Kagawa Y, Hanazono K, et al. Effects of immunosuppressive prednisolone therapy on pancreatic tissue and concentration of canine pancreatic lipase immunoreactivity in healthy dogs. Canadian Journal of Veterinary Research. 2018;82(4):278-86.
4. Puckett Y, Zhang K, Blasingame J, Lorenzana J, Parameswaran S, Brooks SE, et al. Safest time to resume oral anticoagulation in patients with traumatic brain injury. Cureus. 2018;10(7).
5. Xavier AM, Anunciato AKO, Rosenstock TR, Glezer I. Gene expression control by glucocorticoid receptors during innate immune responses. Frontiers in endocrinology. 2016;7:31.
6. Smith SA, Tobias AH, Fine DM, Jacob KA, Ployngam T. Corticosteroid-associated congestive heart failure in 12 cats. Int J Appl Res Vet Med. 2004;2(3):159-70.
7. Hodgens A, Sharman T. Corticosteroids. StatPearls [Internet]: StatPearls Publishing; 2022.
8. Roubille C, Richer V, Starnino T, McCourt C, McFarlane A, Fleming P, et al. The effects of tumour necrosis factor inhibitors, methotrexate, non-steroidal anti-inflammatory drugs and corticosteroids on cardiovascular events in rheumatoid arthritis, psoriasis and psoriatic arthritis: a systematic review and meta-analysis. Annals of the rheumatic diseases. 2015;74(3):480-9.
9. Ployngam T, Tobias AH, Smith SA, Torres SM, Ross SJ. Hemodynamic effects of methylprednisolone acetate administration in cats. American journal of veterinary research. 2006;67(4):583-7.
10. Woolson RF, Bean JA, Rojas PB. Sample size for case-control studies using Cochran's statistic. Biometrics. 1986:927-32.
11. Sebbag L, Mochel JP. Pharmacokinetics of oral prednisone at various doses in dogs: preliminary findings using a naïve pooled-data approach. Frontiers in Veterinary Science. 2020;7:571457.
12. Tinklenberg RL, Murphy SD, Mochel JP, Seo Y-J, Mahaffey AL, Yan Y, et al. Evaluation of dose-response effects of short-term oral prednisone administration on clinicopathologic and hemodynamic variables in healthy dogs. American Journal of Veterinary Research. 2020;81(4):317-25.
13. Rush JE, Freeman LM, Fenollosa NK, Brown DJ. Population and survival characteristics of cats with hypertrophic cardiomyopathy: 260 cases (1990–1999). Journal of the American Veterinary Medical Association. 2002;220(2):202-7.
14. Khelik IA, Berger DJ, Mochel JP, Seo Y-J, Palerme J-S, Ware WA, et al. Clinicopathologic, hemodynamic, and echocardiographic effects of short-term oral administration of anti-inflammatory doses of prednisolone to systemically normal cats. American journal of veterinary research. 2019;80(8):743-55.
15. Sharkey LC, Ployngam T, Tobias AH, Torres SM. Effects of a single injection of methylprednisolone acetate on serum biochemical parameters in 11 cats. Veterinary clinical pathology. 2007;36(2):184-7.
16. Lee S-K, Park S, Cheon B, Kim HW, Yu D, Choi J. Body weight, blood pressure, and systemic changes following low-dosage prednisolone administration in dogs. American journal of veterinary research. 2017;78(9):1091-7.
17. Costa L, Oliveira D, Lopes B, Lanis A, Teixeira M, Costa F. Quantitative computed tomography of the liver in dogs submitted to prednisone therapy. Arquivo Brasileiro de Medicina Veterinária e Zootecnia. 2013;65:1084-90.
18. Twedt DC. The Approach to Abnormal Liver Enzymes in Companion Animals.